DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Akce M, Alese OB, Shaib WL, Wu C, Lesinski GB, El-Rayes BF.
Phase Ib trial of pembrolizumab and XL888 in patients with advanced gastrointestinal malignancies: Results of the dose-escalation phase.
J Clin Oncol 2020;
38 (04) 830
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.